Statement of Organization, Functions, and Delegations of Authority, 82405 [2010-32957]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 250 / Thursday, December 30, 2010 / Notices
likely than other children to be irritable
or to have mild, temporary diarrhea or
vomiting. This happens within the first
week after getting a dose of the vaccine.
Serious Problems: Some studies have
shown a small increase in cases of
intussusception during the week after
the first dose. Intussusception is a type
of bowel blockage that is treated in a
hospital. In some cases surgery might be
required. The estimated risk is 1 case
per 100,000 infants.
What if my child has a severe reaction?
What should I look for?
Any unusual condition, such as a
high fever or behavior changes. Signs of
a severe allergic reaction can include
difficulty breathing, hoarseness or
wheezing, hives, paleness, weakness, a
fast heart beat or dizziness.
What should I do?
Call a doctor, or get the person to a
doctor right away.
Tell the doctor what happened, the
date and time it happened, and when
the vaccination was given.
Ask your doctor to report the reaction
by filing a Vaccine Adverse Event
Reporting System (VAERS) form. Or you
can file this report through the VAERS
Web site at https://www.vaers.hhs.gov, or
by calling 1–800–822–7967. VAERS
does not provide medical advice.
The National Vaccine Injury
Compensation Program
The National Vaccine Injury
Compensation Program (VICP) was
created in 1986.
People who believe they may have
been injured by a vaccine can learn
about the program and about filing a
claim by calling 1–800–338–2382, or
visiting the VICP Web site at https://
www.hrsa.gov/vaccinecompensation.
jlentini on DSKJ8SOYB1PROD with NOTICES
For More Information
• Ask your doctor. They can give you
the vaccine package insert or suggest
other sources of information.
• Call your local or state health
department.
• Contact the Centers for Disease
Control and Prevention (CDC):
—Call 1–800–232–4636 (1–800–CDC–
INFO) or
—Visit CDC’s Web site at https://www.
cdc.gov/vaccines.
Department of Health and Human
Services
Centers for Disease Control and
Prevention
Vaccine Information Statement
(00/00/0000) (Proposed)
42 U.S.C. 300aa–26
VerDate Mar<15>2010
16:35 Dec 29, 2010
Jkt 223001
Dated: December 21, 2010.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention
(CDC).
[FR Doc. 2010–32965 Filed 12–29–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Statement of Organization, Functions,
and Delegations of Authority
Part F of the Statement of
Organization, Functions, and
Delegations of Authority for the
Department of Health and Human
Services, Centers for Medicare &
Medicaid Services (CMS), (last amended
at 75 FR 14176–14178, dated March 24,
2010) is amended to change the title of
the Office of Executive Operations and
Regulatory Affairs to the Office of
Strategic Operations and Regulatory
Affairs, to reflect the establishment of a
new Federal Coordinated Health Care
Office and to update the organization for
CMS, as follows:
(1) Under Part F, CMS, FC. 10
Organizations, change the title of the
Office of Executive Operations and
Regulatory Affairs (FCF) to the Office of
Strategic Operations and Regulatory
Affairs (FCF).
(2) Under Part F, CMS, FC. 10
Organizations, insert the following new
Office after the Center for Medicare and
Medicaid Innovation (FCP): ‘‘Federal
Coordinated Health Care Office (FCQ).’’
(3) Under Part F, CMS, FC. 20
Functions, change the title of the Office
of Executive Operations and Regulatory
Affairs (FCF) to the Office of Strategic
Operations and Regulatory Affairs
(FCF).
(4) Under Part F, CMS, FC. 20
Functions, insert the following after the
description of the Center for Medicare
and Medicaid Innovation (FCP):
Federal Coordinated Health Care Office
(FCQ)
• Manages the implementation and
operation of the Federal Coordinated
Health Care Office mandated in section
2602 of the Affordable Care Act,
ensuring more effective integration of
benefits under Medicare and Medicaid
for individuals eligible for both
programs and improving coordination
between the Federal Government and
States in the delivery of benefits for
such individuals.
• Monitors and reports on annual
total expenditures, health outcomes and
PO 00000
Frm 00034
Fmt 4703
Sfmt 9990
82405
access to benefits for all dual eligible
individuals, including subsets of the
population.
• Coordinates with the Center for
Medicare and Medicaid Innovation to
provide technical assistance and
programmatic guidance related to the
testing of various delivery system,
payment, service and/or technology
models to improve care coordination,
reduce costs, and improve the
beneficiary experience for individuals
dually eligible for Medicare and
Medicaid.
• Performs policy and program
analysis of Federal and State statutes,
policies, rules and regulations
impacting the dual eligible population.
• Makes recommendations on
eliminating administrative and
regulatory barriers between the
Medicare and Medicaid programs.
• Develops tools, resources and
educational materials to increase dual
eligibles’ understanding of and
satisfaction with coverage under the
Medicare and Medicaid programs.
• Provides technical assistance to
States, health plans, physicians and
other relevant entities of individuals
with education and tools necessary for
developing integrated programs for dual
eligible beneficiaries.
• Consults with the Medicare
Payment Advisory Commission and the
Medicaid and CHIP Payment Advisory
Commission with respect to policies
relating to the enrollment in and
provision of benefits to dual eligible
beneficiaries under Medicare and
Medicaid.
• Studies the provision of drug
coverage for new full benefit dual
eligible individuals.
• Develops policy and program
recommendations to eliminate cost
shifting between the Medicare and
Medicaid program and among related
health care providers.
• Develops annual report containing
recommendations for legislation that
would improve care coordination and
benefits for dual eligible individuals.
Authority: 44 U.S.C. 3101.
Dated: December 7, 2010.
Kathleen Sebelius,
Secretary.
[FR Doc. 2010–32957 Filed 12–27–10; 4:15 pm]
BILLING CODE 4120–01–P
E:\FR\FM\30DEN1.SGM
30DEN1
]]>Agencies
[Federal Register Volume 75, Number 250 (Thursday, December 30, 2010)]
[Notices]
[Page 82405]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32957]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
Statement of Organization, Functions, and Delegations of
Authority
Part F of the Statement of Organization, Functions, and Delegations
of Authority for the Department of Health and Human Services, Centers
for Medicare & Medicaid Services (CMS), (last amended at 75 FR 14176-
14178, dated March 24, 2010) is amended to change the title of the
Office of Executive Operations and Regulatory Affairs to the Office of
Strategic Operations and Regulatory Affairs, to reflect the
establishment of a new Federal Coordinated Health Care Office and to
update the organization for CMS, as follows:
(1) Under Part F, CMS, FC. 10 Organizations, change the title of
the Office of Executive Operations and Regulatory Affairs (FCF) to the
Office of Strategic Operations and Regulatory Affairs (FCF).
(2) Under Part F, CMS, FC. 10 Organizations, insert the following
new Office after the Center for Medicare and Medicaid Innovation (FCP):
``Federal Coordinated Health Care Office (FCQ).''
(3) Under Part F, CMS, FC. 20 Functions, change the title of the
Office of Executive Operations and Regulatory Affairs (FCF) to the
Office of Strategic Operations and Regulatory Affairs (FCF).
(4) Under Part F, CMS, FC. 20 Functions, insert the following after
the description of the Center for Medicare and Medicaid Innovation
(FCP):
Federal Coordinated Health Care Office (FCQ)
Manages the implementation and operation of the Federal
Coordinated Health Care Office mandated in section 2602 of the
Affordable Care Act, ensuring more effective integration of benefits
under Medicare and Medicaid for individuals eligible for both programs
and improving coordination between the Federal Government and States in
the delivery of benefits for such individuals.
Monitors and reports on annual total expenditures, health
outcomes and access to benefits for all dual eligible individuals,
including subsets of the population.
Coordinates with the Center for Medicare and Medicaid
Innovation to provide technical assistance and programmatic guidance
related to the testing of various delivery system, payment, service
and/or technology models to improve care coordination, reduce costs,
and improve the beneficiary experience for individuals dually eligible
for Medicare and Medicaid.
Performs policy and program analysis of Federal and State
statutes, policies, rules and regulations impacting the dual eligible
population.
Makes recommendations on eliminating administrative and
regulatory barriers between the Medicare and Medicaid programs.
Develops tools, resources and educational materials to
increase dual eligibles' understanding of and satisfaction with
coverage under the Medicare and Medicaid programs.
Provides technical assistance to States, health plans,
physicians and other relevant entities of individuals with education
and tools necessary for developing integrated programs for dual
eligible beneficiaries.
Consults with the Medicare Payment Advisory Commission and
the Medicaid and CHIP Payment Advisory Commission with respect to
policies relating to the enrollment in and provision of benefits to
dual eligible beneficiaries under Medicare and Medicaid.
Studies the provision of drug coverage for new full
benefit dual eligible individuals.
Develops policy and program recommendations to eliminate
cost shifting between the Medicare and Medicaid program and among
related health care providers.
Develops annual report containing recommendations for
legislation that would improve care coordination and benefits for dual
eligible individuals.
Authority: 44 U.S.C. 3101.
Dated: December 7, 2010.
Kathleen Sebelius,
Secretary.
[FR Doc. 2010-32957 Filed 12-27-10; 4:15 pm]
BILLING CODE 4120-01-P
